Literature DB >> 19298606

Increased prevalence of autoimmunity in Turner syndrome--influence of age.

K H Mortensen1, L Cleemann, B E Hjerrild, E Nexo, H Locht, E M Jeppesen, C H Gravholt.   

Abstract

Individuals with Turner syndrome (TS) are prone to develop autoimmune conditions such as coeliac disease (CD), thyroiditis and type 1 diabetes (T1DM). The objective of the present study was to examine TS of various karyotypes for autoantibodies and corresponding diseases. This was investigated in a prospective cross-sectional study of Danish TS patients (n = 107, median age 36.7 years, range: 6-60 years). A medical history was recorded and a blood sample was analysed for autoantibodies against gliadin, transglutaminase, adrenal cortex, intrinsic factor, anti-thyroid peroxidase (anti-TPO) and glutamic-acid-decarboxylase 65 (GAD-65). Autoantibodies were present in 58% (n = 61) of all patients, whereof 18% (11) had autoantibodies targeting more than one organ. Patients with autoantibodies were significantly older than those without (P = 0.001). Anti-TPO was present in 45% (48) of patients, of whom 33% (16) were hypothyroid. Overall, 18% (19) presented with CD autoantibodies, of whom 26% (five) had CD. Anti-TPO and CD autoantibodies co-existed in 9% (10). Immunoglobulin A deficiency was found in 3% (three) of patients, who all had CD autoantibodies without disease. Among four patients with anti-GAD-65 none had T1DM, but two were classified as having T2DM. One patient had adrenocortical autoantibodies but not adrenal failure. Autoantibodies against intrinsic factor were absent. Anti-GAD-65 was increased in isochromosomal karyotypes (3/23 versus 1/84, P = 0.008) with no other association found between autoantibodies and karyotype. In conclusion, TS girls and women face a high prevalence of autoimmunity and associated disease with a preponderance towards hypothyroidism and CD. Thus, health care providers dealing with this patient group should be observant and test liberally for these conditions even before clinical symptoms emerge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298606      PMCID: PMC2759466          DOI: 10.1111/j.1365-2249.2009.03895.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Premature ovarian failure.

Authors:  G S Conway
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

2.  Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome.

Authors:  S Gupta; S Chiplunkar; A Gupta; S Gollapudi
Journal:  Genes Immun       Date:  2003-04       Impact factor: 2.676

3.  Prevalence and clinical picture of celiac disease in Turner syndrome.

Authors:  Margherita Bonamico; Anna M Pasquino; Paolo Mariani; Helene M Danesi; Franco Culasso; Laura Mazzanti; Antonella Petri; Giovanni Bona
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

4.  Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.

Authors:  J West; R F A Logan; P G Hill; A Lloyd; S Lewis; R Hubbard; R Reader; G K T Holmes; K-T Khaw
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 5.  Turner's syndrome in adulthood.

Authors:  M Elsheikh; D B Dunger; G S Conway; J A H Wass
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

6.  Serum immunoglobulin M, G, and A concentration levels in Turner's syndrome compared with normal women and men.

Authors:  K Jensen; P H Petersen; E L Nielsen; G Dahl; J Nielsen
Journal:  Hum Genet       Date:  1976-03-12       Impact factor: 4.132

7.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Turner's syndrome associated with psoriasis and alopecia areata.

Authors:  P Rosina; G Segalla; M Magnanini; C Chieregato; A Barba
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-01       Impact factor: 6.166

Review 9.  Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.

Authors:  Corrado Betterle; Chiara Dal Pra; Franco Mantero; Renato Zanchetta
Journal:  Endocr Rev       Date:  2002-06       Impact factor: 19.871

10.  Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison's disease in girls and women with Turner syndrome.

Authors:  Annika E Stenberg; Lisskulla Sylvén; Håkan Hedstrand; Olle Kämpe; Malou Hultcrantz
Journal:  J Negat Results Biomed       Date:  2007-12-18
View more
  37 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome.

Authors:  Allison J Pollock; Tasa S Seibert; Cristiana Salvatori; Patrizio Caturegli; David B Allen
Journal:  Horm Res Paediatr       Date:  2016-06-30       Impact factor: 2.852

Review 3.  Current best practice in the management of Turner syndrome.

Authors:  Roopa Kanakatti Shankar; Philippe F Backeljauw
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-18       Impact factor: 3.565

4.  The clinical phenotype of Graves' disease occurring as an isolated condition or in association with other autoimmune diseases.

Authors:  M Rotondi; C Virili; S Pinto; F Coperchini; L Croce; N Brusca; M Centanni; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-08-12       Impact factor: 4.256

Review 5.  The patient with Turner syndrome: puberty and medical management concerns.

Authors:  Luisa Gonzalez; Selma Feldman Witchel
Journal:  Fertil Steril       Date:  2012-08-09       Impact factor: 7.329

6.  Excess female siblings and male fetal loss in families with systemic lupus erythematosus.

Authors:  Rachna Aggarwal; Andrea L Sestak; Eliza F Chakravarty; John B Harley; R Hal Scofield
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

7.  21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.

Authors:  A Berglund; L Cleemann; B E Oftedal; K Holm; E S Husebye; C H Gravholt
Journal:  Clin Exp Immunol       Date:  2018-11-14       Impact factor: 4.330

8.  Delayed β-cell response and glucose intolerance in young women with Turner syndrome.

Authors:  Britta E Hjerrild; Jens J Holst; Claus B Juhl; Jens S Christiansen; Ole Schmitz; Claus H Gravholt
Journal:  BMC Endocr Disord       Date:  2011-03-15       Impact factor: 2.763

9.  Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders.

Authors:  Rebecca Christine Knickmeyer; Marsha Davenport
Journal:  J Neurodev Disord       Date:  2011-08-05       Impact factor: 4.025

10.  Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.

Authors:  Philippe Backeljauw; Shankar Kanumakala; Sandro Loche; Karl Otfried Schwab; Roland Werner Pfäffle; Charlotte Höybye; Elena Lundberg; Tadej Battelino; Berit Kriström; Tomasz Giemza; Hichem Zouater
Journal:  Horm Res Paediatr       Date:  2021-07-07       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.